Avoid common mistakes on your manuscript.
Correction to: Naunyn-Schmiedeberg's Archives of Pharmacology (2022) 395:867–885
We regret to inform readers that our paper (Kayki-Mutlu et al., 2022) had mistakenly stated that tralokinumab “is administered via weekly subcutaneous injection” (p. 873). This should have read that tralokinumab “is administered as a loading dose, followed by subcutaneous injection every other week”. We apologize for any inconvenience this mistake may have caused.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kayki-Mutlu, G., Aksoyalp, Z.S., Wojnowski, L. et al. Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021. Naunyn-Schmiedeberg's Arch Pharmacol 396, 383 (2023). https://doi.org/10.1007/s00210-022-02320-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-022-02320-5